Literature DB >> 20299739

Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis.

Masataka Sata1, Daiju Fukuda.   

Abstract

The renin-angiotensin system (RAS) has been demonstrated to play a critical role in the initiation and progression of atherosclerosis, thereby contributing to development of cardiovascular diseases. Angiotensin II (Ang II), a major substrate in RAS, stimulates atherosclerosis through various deleterious effects such as endothelial dysfunction, cellular proliferation and inflammation. Recently, local RAS in vasculature is reported to play an important role. Many of these atherogenic actions of Ang II are mediated by reactive oxygen species (ROS). Investigation of the role of ROS and inflammation induced by RAS may provide a clue to understanding the pathophysiology of atherosclerotic diseases, and may lead to a new therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299739     DOI: 10.2152/jmi.57.12

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  37 in total

1.  Masked hypertension and effort-reward imbalance at work among 2369 white-collar workers.

Authors:  P Boucher; M Gilbert-Ouimet; X Trudel; C S Duchaine; A Milot; C Brisson
Journal:  J Hum Hypertens       Date:  2017-06-22       Impact factor: 3.012

2.  Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone.

Authors:  Netanya S Utay; Douglas W Kitch; Eunice Yeh; Carl J Fichtenbaum; Michael M Lederman; Jacob D Estes; Claire Deleage; Clara Magyar; Scott D Nelson; Karen L Klingman; Barbara Bastow; Amneris E Luque; Grace A McComsey; Daniel C Douek; Judith S Currier; Jordan E Lake
Journal:  J Infect Dis       Date:  2018-05-05       Impact factor: 5.226

3.  Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.

Authors:  A Grotevendt; H Wallaschofski; M Reincke; C Adolf; M Quinkler; M Nauck; W Hoffmann; R Rettig; A Hannemann
Journal:  Endocrine       Date:  2017-06-22       Impact factor: 3.633

Review 4.  Vitamin D receptor signaling in renal and cardiovascular protection.

Authors:  Yan Chun Li
Journal:  Semin Nephrol       Date:  2013-09       Impact factor: 5.299

5.  Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease.

Authors:  Łukasz Lewicki; Janusz Siebert; Tomasz Koliński; Karolina Piekarska; Magdalena Reiwer-Gostomska; Radosław Targoński; Piotr Trzonkowski; Natalia Marek-Trzonkowska
Journal:  Cardiol J       Date:  2018-03-07       Impact factor: 2.737

6.  Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways.

Authors:  Xiang Xiao; Cheng Zhang; Xiaotang Ma; Huilai Miao; Jinju Wang; Langni Liu; Shuzhen Chen; Rong Zeng; Yanfang Chen; Ji C Bihl
Journal:  Exp Cell Res       Date:  2015-06-19       Impact factor: 3.905

7.  Adiponectin ameliorates angiotensin II-induced vascular endothelial damage.

Authors:  Zuo Zhi; Zuo Pengfei; Tian Xiaoyi; Ma Genshan
Journal:  Cell Stress Chaperones       Date:  2014-02-13       Impact factor: 3.667

Review 8.  Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.

Authors:  Fernando Pedro de Souza-Neto; Melissa Carvalho Santuchi; Mario de Morais E Silva; Maria José Campagnole-Santos; Rafaela Fernandes da Silva
Journal:  Curr Hypertens Rep       Date:  2018-03-14       Impact factor: 5.369

9.  Spironolactone prevents dietary-induced metabolic syndrome by inhibiting PI3-K/Akt and p38MAPK signaling pathways.

Authors:  H D Long; Y E Lin; M J Liu; L Y Liang; Z H Zeng
Journal:  J Endocrinol Invest       Date:  2013-04-23       Impact factor: 4.256

10.  Effect of paricalcitol and enalapril on renal inflammation/oxidative stress in atherosclerosis.

Authors:  Kazim Husain; Edu Suarez; Angel Isidro; Wilfredo Hernandez; Leon Ferder
Journal:  World J Biol Chem       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.